| Sample | Title | Value | Rank |
|---|
| GSM1256958 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 2 | 2186.17 | 99 |
| GSM1256959 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 4 | 1576.3 | 98 |
| GSM1256960 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 7 | 2381.84 | 99 |
| GSM1256961 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 8 | 2951.01 | 99 |
| GSM1256962 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 9 | 2695.93 | 99 |
| GSM1256963 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 12 | 2268.55 | 99 |
| GSM1256972 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 54 before YFV | 1127.08 | 97 |
| GSM1256976 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 54 seven days after YFV | 2929.37 | 99 |
| GSM1256973 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 55 before YFV | 1240.78 | 98 |
| GSM1256977 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 55 seven days after YFV | 1860.42 | 98 |
| GSM1256974 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 56 before YFV | 1047.88 | 97 |
| GSM1256978 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 56 seven days after YFV | 2061.9 | 99 |
| GSM1256975 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 57 before YFV | 1566.06 | 98 |
| GSM1256979 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 57 seven days after YFV | 1935.44 | 98 |